Quality of LifeDouble-Blind MethodPancreatic NeoplasmsElectroencephalographyInterviews as TopicPalliative CareHospitalizationClinical Trials as TopicPain MeasurementActivities of Daily LivingEvaluation Studies as TopicRandom AllocationInfusion PumpsAnalgesicsSelf Administration
Dr. Juhl studies a range of topics centering on how to better manage symptoms and improve quality of life for patients with severe illnesses, particularly those with cancer and respiratory needs. He explores palliative care approaches for conditions like pancreatic cancer, emphasizing strategies that allow patients to have longer lives with fewer hospital visits. He also investigates the emotional and physical impacts of various treatments, such as percutaneous nephrostomy, which is used to relieve obstructions in urine flow for cancer patients. Furthermore, Dr. Juhl evaluates medications and devices designed to manage pain effectively, including opioids for cancer pain and innovative equipment that ensures safe delivery of treatments in pediatric patients.
Key findings
Patients with unresectable pancreatic cancer receiving early palliative care lived 8 months on average compared to 4.9 months for those receiving standard care.
In a study of male cancer patients, percutaneous nephrostomy improved symptoms but limited physical activity and social lives, causing frustration due to complications.
A special face mask for infants kept CO2 levels low (3.2% for normal breathing) during aerosol medication delivery, ensuring safety.
Ketamine significantly reduced ongoing pain and touch-induced pain in nerve injury patients, while lidocaine predominantly helped with pain from specific touch stimuli.
Gabapentin reduced sensitivity to light touch pain in healthy volunteers compared to a placebo, elucidating its effects on chronic nerve pain.
Frequently asked questions
Does Dr. Juhl study pain management?
Yes, Dr. Juhl specializes in pain management, particularly in cancer patients and those with nerve injuries.
What conditions does Dr. Juhl focus on?
He focuses on serious conditions like pancreatic cancer, prostate cancer, and nerve injuries, examining both treatment effectiveness and patient experiences.
Has Dr. Juhl researched any devices for patients?
Yes, he has studied devices that help manage pain and deliver medications safely, particularly for infants and during surgical procedures.
Are Dr. Juhl's findings relevant for cancer patients?
Absolutely, his research offers valuable insights into pain management and supportive care strategies for cancer patients.
What are some treatments Dr. Juhl has explored?
He has explored the use of opioids for cancer pain relief, percutaneous nephrostomy for urinary blockages, and gabapentin for neuropathic pain.
Publications in plain English
Early Specialized Palliative Care for Unresectable Pancreatic Cancer: A Quasi-Experimental Study.
2026
Journal of pain and symptom management
Dufva I, Juhl G, Andersen F, Beier-Holgersen R, Maddocks M
Plain English This study looked at the effects of early specialized palliative care on patients with advanced pancreatic cancer that couldn't be surgically removed. The researchers found that patients who received this care lived longer (8 months versus 4.9 months) and experienced fewer hospital visits and stays. This is significant because it shows that patients can enjoy longer lives and better manage their health without relying heavily on hospital services.
Who this helps: This benefits patients with unresectable pancreatic cancer and their families.
A qualitative study exploring male cancer patients' experiences with percutaneous nephrostomy.
2015
Scandinavian journal of urology
Bigum LH, Spielmann ME, Juhl G, Rasmussen A
Plain English This study looked at how male cancer patients feel about a treatment called percutaneous nephrostomy, which is used when urine flow is blocked due to advanced cancer. Researchers interviewed ten men, most of whom had prostate or bladder cancer, and found that while the treatment often improved symptoms, it also limited their physical activity and social lives and led to feelings of frustration when complications required hospital visits. Understanding these experiences is important for better patient care, as it highlights the need for clear communication about the benefits and challenges of the procedure.
Who this helps: This helps cancer patients and their healthcare providers.
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.
2012
The Lancet. Oncology
Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C +22 more
Plain English This research paper outlines updated guidelines from the European Association for Palliative Care on how to use opioid painkillers for treating cancer pain. A panel of experts reviewed previous guidelines and current research, resulting in 16 clear recommendations for healthcare providers. This matters because it provides reliable, evidence-based strategies to help manage cancer pain effectively, improving the quality of life for patients.
Who this helps: Cancer patients experiencing pain.
Assessing Modeled CO(2) Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants.
2012
ISRN pediatrics
Mundt C, Sventitskiy A, Cehelsky JE, Patters AB, Tservistas M +3 more
Plain English This study looked at a special face mask designed for infants that delivers aerosol medications effectively while ensuring safety. Researchers found that when infants used the mask, the carbon dioxide (CO2) levels inside it stayed low, reaching 3.2% for normal breathing and 3% for distressed breathing, which means that it's unlikely to harm them during use. This matters because it confirms that the mask can safely deliver important treatments without posing a risk of CO2 buildup in young children.
Who this helps: This benefits infants needing respiratory treatments and their caregivers.
Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain.
2006
Anesthesiology
Gottrup H, Bach FW, Juhl G, Jensen TS
Plain English This study looked at how two different medications, ketamine and lidocaine, affected pain in patients who have nerve injuries. The researchers found that ketamine significantly reduced both ongoing pain and pain caused by touch, while lidocaine mostly helped with pain from a specific type of touch (like a pinprick). Understanding how these drugs work can help improve pain management for those dealing with nerve injury pain.
Who this helps: This benefits patients with nerve injuries who are seeking relief from pain.
Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia.
2004
Anesthesiology
Gottrup H, Juhl G, Kristensen AD, Lai R, Chizh BA +3 more
Plain English This study looked at how the drug gabapentin affects pain response in healthy volunteers. Researchers applied capsaicin, a substance that causes pain, on the skin of 41 men and then gave them either gabapentin or a placebo for 15 days. Those taking gabapentin showed a significant decrease in sensitivity to light touch pain compared to those taking the placebo, which could help explain how gabapentin relieves pain in people with chronic nerve pain.
Who this helps: This benefits patients suffering from chronic neuropathic pain.
[Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
1990
EEG-EMG Zeitschrift fur Elektroenzephalographie, Elektromyographie und verwandte Gebiete
Suttmann H, Rampf U, Juhl G, Greim M, Doenicke A
Plain English This study looked at how different doses of benzodiazepines, a class of sedative medications, affect brain activity in 32 young men. Researchers found that as the dose increased, the brain's beta activity also increased after a short delay, peaking about 2 to 3 minutes after injection. Importantly, the effects of these medications could be reversed with a specific antidote, flumazenil, which demonstrates a clear interaction between the sedatives and the antagonist.
Who this helps: This research benefits doctors and healthcare providers in managing sedation and reversing overdoses in patients.
Six-year results of annual colonoscopy after resection of colorectal cancer.
1990
World journal of surgery
Juhl G, Larson GM, Mullins R, Bond S, Polk HC
Plain English This study followed 174 patients who had colon cancer surgery to see how effective annual colonoscopies are in finding new cancers and other issues after their treatment. They found that 57 patients experienced a return of colorectal cancer, with most recurrences happening within the first two years, and they detected new cancers and significant polyps in several others. The results show that doing colonoscopies annually for at least the first six years after surgery is important for catching new tumors and growths.
Who this helps: This helps patients who have undergone colorectal cancer surgery.
[The Infucommand. A PCA (patient-controlled analgesia) device using pulsoximetric bolus control].
1990
Der Anaesthesist
Juhl G
Plain English This study looked at a new device called Infucommand that improves patient-controlled pain management by monitoring breathing. It uses a special sensor to check oxygen levels and automatically stops the pain medication if oxygen levels drop too low, reducing the risk of opioid overdose. This is important because it helps keep patients safe while they manage their pain.
Who this helps: Patients using opioid medications for pain relief.
[Visual EEG analysis in controlling intravenous anesthesia using propofol].
1989
Der Anaesthesist
Suttmann H, Juhl G, Baur B, Morgenstern W, Doenicke A
Plain English This study looked at using brain wave patterns, recorded from EEGs, to manage anesthesia during surgeries using a drug called Propofol. They found that by carefully monitoring brain activity, they could keep patients in either light sleep or deep sleep during operations that lasted between 70 and 190 minutes. The results showed that using EEG monitoring helps ensure patients are kept at the right level of sedation during surgery, which is important for their safety and comfort.
Who this helps: This helps patients undergoing surgeries that require anesthesia.
[Patient-controlled analgesia. A technical toy or a contribution to the treatment of pain?].
1988
Der Anaesthesist
Suttmann H, Juhl G, Florian W, Dworzak H, Ebentheuer H
Plain English This study looked at how effective patient-controlled analgesia (PCA) is for managing pain after surgery. It involved 82 patients receiving either pentazocine or fentanyl, two different pain medications, and found that both were equally effective in reducing pain. On average, patients used less pain medication over time, with pentazocine doses dropping from 55 mg to 31.5 mg every 4 hours, and fentanyl doses decreasing from 0.28 mg to 0.18 mg every 4 hours in the first 16 hours after surgery, while most patients had a very positive experience with PCA and reported few side effects.
Who this helps: This benefits postoperative patients seeking effective pain management after surgery.
Plain English This study focused on a new device called Infucommand III that controls infusion pumps used in medical treatments. Researchers found that this microcomputer makes it easy to manage multiple infusion pumps together, improving safety and efficiency during procedures. Initial tests showed it works well in patient-controlled and EEG-controlled anesthesia, indicating its potential for better patient care.
Who this helps: This helps patients undergoing complex treatments and doctors who need reliable infusion systems.